of which begins after December 31, 2027. . (b) Elective payment Section 6417(a) of the Internal Revenue Code of 1986, as amended by section 2(b) of this Act, is amended by adding at the end the following new paragraph: (14) The generic drugs and biosimilars investment credit determined under section 48F. . (c) Conforming amendments (1) Section 46 is amended— (A) in paragraph (6), by striking and at the end, (B) in paragraph (7), by striking the period at the end and inserting , and , and (C) by adding at the end the following: (8) the generic drugs and biosimilars investment credit. . (2) Section 49(a)(1)(C) is amended— (A) by striking and at the end of clause (vi), (B) by striking the period at the end of clause (vii) and inserting a comma, and (C) by adding at the end the following new clause: (viii) the basis of any qualified property which is part of a qualified facility under section 48F. . (3) The table of sections for subpart E of part IV of subchapter A of chapter 1 is amended by inserting after the item relating to section 48E the following new item: 48F. Generic drugs and biosimilars investment credit. . (d) Effective date The amendments made by this section shall apply to property placed in service after December 31, 2025.